Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma-Reference-Cited by-同舟云学术

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma

Published:2015-10-29 Issue:4 Volume:5 Page:e1105429
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Capasso Cristian,Hirvinen Mari,Garofalo Mariangela,Romaniuk Dmitrii,Kuryk Lukasz,Sarvela Teea,Vitale Andrea,Antopolsky Maxim,Magarkar Aniket,Viitala Tapani,Suutari Teemu,Bunker Alex,Yliperttula Marjo,Urtti Arto,Cerullo Vincenzo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2015.1105429

Reference40 articles.

1. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

2. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

3. Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF

4. Dendritic Cell Function After Gene Transfer with Adenovirus-calcium Phosphate Co-precipitates

5. Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge research frontiers in oral cavity vaccines for respiratory diseases: a roadmap for scientific advancement;Frontiers in Cellular and Infection Microbiology;2024-06-26

2. Oncolytic adenoviruses and immunopeptidomics: a convenient marriage;Molecular Oncology;2024-04

3. Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy;Molecular Therapy: Oncology;2024-03

4. PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines;International Journal of Biological Macromolecules;2024-03

5. Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors;Journal for ImmunoTherapy of Cancer;2024-03